The COI Office provides oversight for the University's institutional, research, faculty, and staff conflict of interest policies and procedures.
We help to ensure university compliance with applicable regulatory requirements, those include rules in place by federal funding agencies for research and also laws that govern state employment.
WVU COI and Related Policies
-
BOG Governance Rule 1.4
Ethics, conflicts of interest, and outside consulting arrangements -
Faculty Handbook
Faculty Responsibilities -
BOG Governance Rule 1.5
Intellectual property rule for patent, copyright, and trademark rights - WVU School of Medicine Code of Conduct – Conflicts of Interest and Conflicts of Commitment (PDF)
WVU Guidance documents related to COI
- Ethics, Conflicts of Interest and Outside Consulting Arrangements FAQs
- Outside Consulting Arrangements Do's and Don’ts
Federal and State Resources
- Department of Health and Human Services 42 CFR Part 50 and 45 CRF Part 94: Responsibility of Applicants for Promoting Objectivity in Research for which Public Health Services Funding is Sought and Responsible Prospective Contractors (August 2011)
- NIH Policy Clarification on Sponsored or Reimbursed Travel (10/18/2012)
- NIH Office of Extramural Research. Charting a Renewed Course for Managing Financial Conflicts of Interest. (August 2011)
- The Physician Payments Sunshine provision, formally called the Transparency Reports and Reporting of Physician Ownership or Investment Interests, was enacted as §6002 of the Patient
- Protection and Affordable Care Act (Pub. L. No. 11-148), the federal health-care reform legislation (March 2010)
- OHRP/HHS Draft “Financial Relationships and Interests in Research Involving Human Subjects: Guidance for Human Subject Protection”(April 2003)
- “Financial Conflicts of Interest and Research Objectivity: Issues for Investigators and Institutional Review Boards”, NIH Guide. (June 5, 2000)
- Frequently asked questions Concerning the Department of Health and Human Services Objectivity in Research Regulations and the National Science Foundation Investigator Financial Disclosure Policy. (July 3,1996)
- “Objectivity in Research”, NIH Guide (PHS, July 14,1995)
- FDA “Guidance: Financial Disclosure by Clinical Investigators” (March 20, 2001)
- NSF “Chapter IV – Grantee Standards” Conflict of Interest Policies (January 25, 2016)
- West Virginia Ethics Act